Sebastian Heersink, MD
Ophthalmology · Dothan, ALNPI 1376701391
Payments from drug & device makers
Across 1,654 payments — averaging $2368.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$2M
- AbbVie$911K
- Ocular Therapeutix, Inc.$512K
- Alcon Research LLC$337K
- Sight Sciences, Inc.$119K
- Johnson & Johnson Surgical Vision, Inc.$15K
- plus $28K from 25 others
Across 2 payments — averaging $3184.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Glaukos Corporation$4K
- Ocular Therapeutix, Inc.$3K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 553 | $1,993,292 |
| AbbVie(2 entities) | 240 | $911,216 |
| Ocular Therapeutix, Inc. | 8 | $512,184 |
| Alcon Research LLC | 623 | $337,473 |
| Sight Sciences, Inc. | 17 | $119,442 |
| Johnson & Johnson Surgical Vision, Inc. | 11 | $15,332 |
| Sun Pharmaceutical Industries Inc. | 8 | $6,453 |
| Oyster Point Pharma, Inc. | 6 | $5,719 |
| Eyepoint US, Inc. | 6 | $4,527 |
| Carl Zeiss Meditec Cataract Technology Inc. | 2 | $4,011 |
| Iridex Corporation | 3 | $2,029 |
| Ivantis, Inc | 9 | $820 |
| Alcon | 35 | $605 |
| Omeros Corporation | 34 | $559 |
| Rayner Intraocular Lenses Limited | 26 | $498 |
| Nordic Pharma, Inc. | 1 | $480 |
| Carl Zeiss Meditec, Inc. | 1 | $400 |
| NEW World Medical,inc. | 18 | $224 |
| Novartis | 11 | $197 |
| Tarsus Pharmaceuticals, Inc. | 10 | $195 |
| Bausch & Lomb Americas Inc. | 8 | $183 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $158 |
| Dompe US, Inc. | 2 | $146 |
| Amgen | 1 | $120 |
| Harrow Eye, LLC | 5 | $116 |
| Quidel Corporation | 1 | $82 |
| Kala Pharmaceuticals, Inc. | 4 | $64 |
| Nova Eye, Inc. | 2 | $62 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Rxsight Inc | 1 | $26 |
| Shire North American Group Inc | 1 | $25 |
How this compares
$3,916,678 in reported general payments places this provider in the 95th percentile of 197 ophthalmology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other ophthalmology in Dothan
- Harsha SenDothan$140K
- Marnix HeersinkDothan$19K
- Kirk SturridgeDothan$11K
- Aaron McKinleyDothan$8K
- Warren ThompsonDothan$6K
- Marius HeersinkDothan$3K
- Bret FisherHomewood$821K
- Caroline WatsonHuntsville$292K
- Ronald GrossFairhope$254K
- Ann Arciniegas-BernalBirmingham$142K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.